SZ 469 (Glimepiride and Pioglitazone Hydrochloride 4 mg / 30 mg (base))
Pill with imprint SZ 469 is White, Elliptical / Oval and has been identified as Glimepiride and Pioglitazone Hydrochloride 4 mg / 30 mg (base). It is supplied by Sandoz Inc..
Glimepiride/pioglitazone is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. Glimepiride/pioglitazone 4 mg / 30 mg (base) is not a controlled substance under the Controlled Substances Act (CSA).
Images for SZ 469
Glimepiride and Pioglitazone Hydrochloride
- Imprint
- SZ 469
- Strength
- 4 mg / 30 mg (base)
- Color
- White
- Shape
- Elliptical / Oval
- Availability
- Prescription only
- Drug Class
- Antidiabetic combinations
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Sandoz Inc.
- National Drug Code (NDC)
- 00781-5635
More about glimepiride / pioglitazone
- Side Effects
- During Pregnancy
- Dosage Information
- Imprints, Shape & Color Data
- Drug Interactions
- Pricing & Coupons
- En Español
- 1 Review
- Drug class: antidiabetic combinations
- FDA Alerts (2)
Consumer resources
- Other brands
- Duetact
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.